This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n18http://localhost/temp/predkladatel/
n13http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n9http://linked.opendata.cz/resource/domain/vavai/subjekt/
n8http://linked.opendata.cz/ontology/domain/vavai/
n11http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n15http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216224%3A14740%2F11%3A00052839%21RIV12-MSM-14740___/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n4http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216224%3A14740%2F11%3A00052839%21RIV12-MSM-14740___
rdf:type
skos:Concept n8:Vysledek
dcterms:description
One of the fundamental prerequisites of the successful schizophrenia treatment is represented by an adequately significant impact on the negative symptoms of schizophrenia. Since the present pharmacotherapy has probably reached its limit in this area, there is a logical effort to utilize other, non-pharmacological methods. One of the most promising supplements that has been for a long time verified in the clinical practice is rTMS. Most of the studies have arrived at the conclusion that rTMS is an efficient method in the treatment of negative symptoms of schizophrenia. A valuable contribution to the assessment of the rTMS application in the treatment of negative symptoms is represented by meta-analyses. The metaanalyses indicate that the effect is mild to moderate (d=0.43 to 0.68). To sum it up, there will be higher probability of the rTMS effect on negative symptoms if 10 Hz stimulating frequency and a longer stimulation period in the extent at least three, ideally four to six weeks is used. One of the fundamental prerequisites of the successful schizophrenia treatment is represented by an adequately significant impact on the negative symptoms of schizophrenia. Since the present pharmacotherapy has probably reached its limit in this area, there is a logical effort to utilize other, non-pharmacological methods. One of the most promising supplements that has been for a long time verified in the clinical practice is rTMS. Most of the studies have arrived at the conclusion that rTMS is an efficient method in the treatment of negative symptoms of schizophrenia. A valuable contribution to the assessment of the rTMS application in the treatment of negative symptoms is represented by meta-analyses. The metaanalyses indicate that the effect is mild to moderate (d=0.43 to 0.68). To sum it up, there will be higher probability of the rTMS effect on negative symptoms if 10 Hz stimulating frequency and a longer stimulation period in the extent at least three, ideally four to six weeks is used. One of the fundamental prerequisites of the successful schizophrenia treatment is represented by an adequately significant impact on the negative symptoms of schizophrenia. Since the present pharmacotherapy has probably reached its limit in this area, there is a logical effort to utilize other, non-pharmacological methods. One of the most promising supplements that has been for a long time verified in the clinical practice is rTMS. Most of the studies have arrived at the conclusion that rTMS is an efficient method in the treatment of negative symptoms of schizophrenia. A valuable contribution to the assessment of the rTMS application in the treatment of negative symptoms is represented by meta-analyses. The metaanalyses indicate that the effect is mild to moderate (d=0.43 to 0.68). To sum it up, there will be higher probability of the rTMS effect on negative symptoms if 10 Hz stimulating frequency and a longer stimulation period in the extent at least three, ideally four to six weeks is used.
dcterms:title
Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia
skos:prefLabel
Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia Repetitive transcranial magnetic stimulation and treatment of negative symptoms of schizophrenia
skos:notation
RIV/00216224:14740/11:00052839!RIV12-MSM-14740___
n8:predkladatel
n9:orjk%3A14740
n3:aktivita
n10:Z
n3:aktivity
Z(MSM0021622404)
n3:cisloPeriodika
2
n3:dodaniDat
n4:2012
n3:domaciTvurceVysledku
n13:4520831
n3:druhVysledku
n17:J
n3:duvernostUdaju
n19:S
n3:entitaPredkladatele
n15:predkladatel
n3:idSjednocenehoVysledku
226577
n3:idVysledku
RIV/00216224:14740/11:00052839
n3:jazykVysledku
n14:cze
n3:klicovaSlova
negative symptoms; repetitive transcranial magnetic stimulation; rTMS; schizophrenia; treatment
n3:klicoveSlovo
n7:schizophrenia n7:treatment n7:repetitive%20transcranial%20magnetic%20stimulation n7:negative%20symptoms n7:rTMS
n3:kodStatuVydavatele
SE - Švédské království
n3:kontrolniKodProRIV
[F5C2D79622A5]
n3:nazevZdroje
Neuroendocrinology Letters
n3:obor
n12:FL
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
1
n3:rokUplatneniVysledku
n4:2011
n3:svazekPeriodika
32
n3:tvurceVysledku
Přikryl, Radovan
n3:wos
000293493800002
n3:zamer
n11:MSM0021622404
s:issn
0172-780X
s:numberOfPages
6
n18:organizacniJednotka
14740